These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25782922)

  • 21. Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.
    Park S; Baek CH; Go H; Kim YH; Min SI; Ha J; Kim YC; Lee JP; Kim YS; Moon KC; Park SK; Lee H
    BMC Nephrol; 2019 Sep; 20(1):354. PubMed ID: 31510954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme genotype and chronic allograft nephropathy in protocol biopsies.
    Hueso M; Alía P; Moreso F; Beltrán-Sastre V; Riera L; González C; Navarro MA; Grinyó JM; Navarro E; Serón D
    J Am Soc Nephrol; 2004 Aug; 15(8):2229-36. PubMed ID: 15284309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.
    Cosio FG; Frankel WL; Pelletier RP; Pesavento TE; Henry ML; Ferguson RM
    Am J Kidney Dis; 1999 Oct; 34(4):731-8. PubMed ID: 10516356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
    Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
    Hart A; Jackson S; Kasiske BL; Mauer MS; Najafian B; Matas AJ; Spong R; Ibrahim HN
    Transplantation; 2014 May; 97(10):1066-71. PubMed ID: 24503762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
    Savin M; Petronić V
    Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
    Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z
    Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.
    Ohashi N; Isobe S; Ishigaki S; Suzuki T; Ono M; Fujikura T; Tsuji T; Kato A; Ozono S; Yasuda H
    Hypertens Res; 2017 Apr; 40(4):364-370. PubMed ID: 27761002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-β1 expression in kidney allograft protocol biopsies during cyclosporine A therapy.
    Ortiz F; Helanterä IT; Räisänen-Sokolowski A; Honkanen EO; Koskinen PK
    Int J Artif Organs; 2013 Jan; 36(1):56-62. PubMed ID: 23280075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mineralocorticoid receptor antagonism and aldosterone synthesis inhibition do not improve glomerulosclerosis and renal interstitial fibrosis in a model of chronic kidney allograft injury.
    Lahmer T; Hermans R; Schmaderer C; Chang J; Stock K; Lutz J; Heemann U; Baumann M
    Kidney Blood Press Res; 2012; 35(6):561-7. PubMed ID: 22890233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered renal expression of angiotensin II receptors, renin receptor, and ACE-2 precede the development of renal fibrosis in aging rats.
    Schulman IH; Zhou MS; Treuer AV; Chadipiralla K; Hare JM; Raij L
    Am J Nephrol; 2010; 32(3):249-261. PubMed ID: 20689271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II-mediated renal injury.
    Harris RC; Martinez-Maldonado M
    Miner Electrolyte Metab; 1995; 21(4-5):328-35. PubMed ID: 7565481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft nephropathy.
    Becker BN; Jacobson LM; Hullett DA; Radke NA; Oberley TD; Brazy PC; Kirk AD
    Clin Nephrol; 2002 Jan; 57(1):19-26. PubMed ID: 11837798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early activation of fibrogenesis in transplanted kidneys: a study on serial renal biopsies.
    Del Prete D; Ceol M; Anglani F; Vianello D; Tiralongo E; Valente M; Graziotto R; Bonfante L; Scaparrotta G; Furian L; Rigotti P; Gambaro G; D'Angelo A
    Exp Mol Pathol; 2009 Oct; 87(2):141-5. PubMed ID: 19616542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the current chronic allograft nephropathy grading systems sufficient to predict renal allograft survival?
    Moscoso-Solorzano GT; Mastroianni-Kirsztajn G; Ozaki KS; Araujo S; Franco MF; Pacheco-Silva A; Camara NO
    Braz J Med Biol Res; 2008 Oct; 41(10):896-903. PubMed ID: 18853041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.
    Kovarik JJ; Kaltenecker CC; Kopecky C; Domenig O; Antlanger M; Werzowa J; Eskandary F; Kain R; Poglitsch M; Schmaldienst S; Böhmig GA; Säemann MD
    Sci Rep; 2019 Jul; 9(1):9762. PubMed ID: 31278281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids.
    Debelle FD; Nortier JL; Husson CP; De Prez EG; Vienne AR; Rombaut K; Salmon IJ; Deschodt-Lanckman MM; Vanherweghem JL
    Kidney Int; 2004 Nov; 66(5):1815-25. PubMed ID: 15496152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
    Boratyńska M
    Ann Transplant; 1999; 4(2):23-8. PubMed ID: 10850587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.